Careers in Discovery

Careers in Discovery is your window into the world of Pharma & Biotech. Featuring interviews each week with leaders in Drug Discovery and R&D, you’ll learn about the careers of these influential figures, the work they are doing, how they got to where they are and what advice they’d give their younger selves.Brought to you by Singular Talent. Connect with us at:Twitter: @singular_talentLinkedIn: www.linkedin.com/company/singular-talentwww.singulartalent.io

Careers in Discovery is a business podcast hosted by Tom Froggatt, with 100 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

Tom Froggatt hosts Careers in Discovery, a business show with 100 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  Episode #214

  Grahame Mckenzie, Sentinel Oncology

  Jun 24, 202638 min

  Most Biotech careers aren’t built on big breakthroughs; they’re built on tough calls. In this episode, Grahame Mackenzie shares what it really takes to build in Biotech, from scaling tiny teams into clinic-delivering companies to knowing when to kill your own projects. He breaks down the mindset shift many scientists struggle with letting go of emotional attachment to the science, making ruthless decisions, and focusing on what turns into a drug. Grahame’s message is clear: the difference isn’t ideas, it’s the people you build with, and the decisions you’re willing to make.

  ListenShow Notes
• 

  Episode #213

  Andrea Braun-Scherhag, SVP Global Head of Regulatory Affairs & Safety

  Jun 10, 202639 min

  In this episode, Andrea Braun-Scherhag, SVP and Global Head of Regulatory Affairs & Safety at Autolus, breaks down what it really takes to bring breakthrough therapies to market, especially when there’s no established playbook. From securing rapid global approvals to navigating entirely new pathways in cell and gene therapy, she shares why regulatory sits at the centre of Biotech success. Andrea challenges the common perception of regulatory as operational, revealing it instead as one of the most impactful, forward-looking functions in any biotech. She also highlights the importance of engaging regulators early, aligning teams behind a clear strategy, and putting patients at the heart of development, particularly in rare diseases.

  ListenShow Notes
• 

  Episode #212

  Dan Tardiff, CAMP4 Therapeutics

  May 27, 202641 minS0

  <p>What does it really take to progress from bench science to leading a Biotech platform as Chief Scientific Officer?</p> <p>In this episode of Careers in Discovery, Daniel Tardiff, CSO at Camp4 Therapeutics, shares a candid look at building and scaling science inside an early‑stage biotech. From his foundations in RNA biology to advancing antisense programmes for haploinsufficiency-driven neurodevelopmental disorders, Dan unpacks how translational judgement is developed over time, not taught.</p> <p>Key takeaway: Career progression isn’t about having perfect answers. It’s about making credible decisions under uncertainty and bringing others with you as the sc...

  ListenShow Notes
• 

  Episode #211

  Adrian Gabriel Torres, Aptadel Therapeutics

  May 13, 202641 minS0

  <p>In this episode of Careers in Discovery, Adrian Gabriel Torres, Chief Scientific Officer at Aptadel Therapeutics, talks about developing RNA aptamer–based cancer therapies and leading scientific strategy in a preclinical biotech start-up. Adrian also shares his journey from academic research into industry, reflecting on the differences between academia and biotech, learning new skill sets, managing teams, and making career decisions along the way.</p>

  ListenShow Notes
• 

  Episode #210

  Rachel Abbott, Pan Cancer T

  Apr 29, 202638 minS0

  <p>This week on Careers on Discovery, we’re joined by Rachel Abbott, CEO of Pan Cancer T.</p> <p>Rachel shares her journey from academic science into biotech leadership, reflecting on the pivotal moments that shaped her career - from early setbacks at university to working on T‑cell therapies that reached patients, and ultimately stepping into a first‑time CEO role. We discuss Pan Cancer T’s work developing next‑generation T‑cell therapies for solid tumours, and the challenges of translating complex science into the clinic.</p> <p>She also reflects on confidence, resilience, and why saying yes to oppor...

  ListenShow Notes

Recent guests on Careers in Discovery. Study who booked and why before you pitch.

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.